Health
Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 variants – News-Medical.Net
A team of researchers in the U.S. studied the Pfizer-BioNTech vaccine candidate – currently being rolled out in many parts of the world to high-risk individuals…
The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, has led to over 103 million infections over 2.2 million deaths worldwide. With no targeted, effective antivirals and safe antivirals yet identified, the focus has largely been on non-pharmaceutical interventions (NPIs). These have included scrupulous attention to handwashing, wearing masks in public, social distancing and lockdowns at various (regional…
Continue Reading